These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15576016)

  • 1. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana.
    Ohene Buabeng K; Matowe L; Plange-Rhule J
    J Pharm Pharm Sci; 2004 Nov; 7(3):350-2. PubMed ID: 15576016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians.
    Amira CO; Okubadejo NU
    Niger Postgrad Med J; 2007 Dec; 14(4):325-9. PubMed ID: 18163143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension treatment compliance: what do patients want to know about their medications?
    Bailey BJ; Carney SL; Gillies AH; McColm LM; Smith AJ; Taylor M
    Prog Cardiovasc Nurs; 1997; 12(4):23-8. PubMed ID: 9433730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy and non-compliance in the hypertensive elderly patient.
    Fonseca T; Clara JG
    Rev Port Cardiol; 2000 Sep; 19(9):855-72. PubMed ID: 11109869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient's view of hypertension and compliance.
    Sharkness CM; Snow DA
    Am J Prev Med; 1992; 8(3):141-6. PubMed ID: 1632999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of socio-economic factors on the compliance of patients with treatment of hypertonic disease].
    Serov VA; Gorbunov VI
    Klin Med (Mosk); 2007; 85(3):65-8. PubMed ID: 17523410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
    Taira DA; Wong KS; Frech-Tamas F; Chung RS
    Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug compliance among hypertensive patients in Kassala, eastern Sudan.
    Elzubier AG; Husain AA; Suleiman IA; Hamid ZA
    East Mediterr Health J; 2000 Jan; 6(1):100-5. PubMed ID: 11370321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.
    Burnier M
    Am J Hypertens; 2006 Nov; 19(11):1190-6. PubMed ID: 17070434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence.
    Cramer JA
    Am J Manag Care; 1998 Nov; 4(11):1563-8. PubMed ID: 10338902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive drug medication adherence and its affecting factors in South Korea.
    Park JH; Shin Y; Lee SY; Lee SI
    Int J Cardiol; 2008 Aug; 128(3):392-8. PubMed ID: 17643514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obstacles to medication compliance for patients with glaucoma].
    Kowal M; Choragiewicz T; Mietlicka K; Wyszyńska A; Zarnowski T
    Klin Oczna; 2008; 110(10-12):347-51. PubMed ID: 19195163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance to antihypertensive therapy.
    Almas A; Hameed A; Ahmed B; Islam M
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):23-6. PubMed ID: 16441983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the difference in medication compliance between the general patient population and patients receiving antihypertensive therapy: a case study.
    Culig J; Leppée M; Boskovic J; Eric M
    Arch Pharm Res; 2011 Jul; 34(7):1143-52. PubMed ID: 21811921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad.
    Ahmed N; Abdul Khaliq M; Shah SH; Anwar W
    J Ayub Med Coll Abbottabad; 2008; 20(2):66-9. PubMed ID: 19385461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose combinations improve medication compliance: a meta-analysis.
    Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
    Am J Med; 2007 Aug; 120(8):713-9. PubMed ID: 17679131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors in the Bedouin population: management and compliance.
    Tamir O; Peleg R; Dreiher J; Abu-Hammad T; Rabia YA; Rashid MA; Eisenberg A; Sibersky D; Kazanovich A; Khalil E; Vardy D; Shvartzman P
    Isr Med Assoc J; 2007 Sep; 9(9):652-5. PubMed ID: 17939626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with medication noncompliance in rural elderly hypertensive patients.
    McLane CG; Zyzanski SJ; Flocke SA
    Am J Hypertens; 1995 Feb; 8(2):206-9. PubMed ID: 7755952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of patient compliance among hypertensive patients treated by specialists].
    Girerd X; Radauceanu A; Achard JM; Fourcade J; Tournier B; Brillet G; Silhol F; Hanon O
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):839-42. PubMed ID: 11575214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.